Actively Recruiting
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Led by Pfizer · Updated on 2025-12-08
183
Participants Needed
30
Research Sites
251 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to learn about the safety and effects of Abrocitinib in the real-life clinical setting given for the treatment of moderate to severe atopic dermatitis. Atopic dermatitis, or AD, is a long-lasting disease that causes inflammation, redness, and irritation of the skin. This study is seeking participant who are older than 18 years with moderate-to-severe chronic AD. Participants must have no underlying medical conditions that prevent them from taking Abrocitinib. All participants in this study will receive Abrocitinib as a tablet once daily. They can take Abrocitinib and use medicated topical treatment for AD at the same time. We will examine the experiences of patients receiving the study medicine. This will help us determine if the study medicine is safe and helps in treating AD. Participants will take part in this study for 24 months. During this time, they will visit the study clinic about 5 times (about 1 time every 4 to 6 months).
CONDITIONS
Official Title
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients older than 18 years of age at inclusion.
- Patients with clinical diagnosis of moderate-to-severe chronic atopic dermatitis at inclusion according to the investigator and eligible for abrocitinib according to its marketing approval.
- Patients that have been informed of the study procedures and have signed the consent.
You will not qualify if you...
- Patients for whom abrocitinib is contraindicated.
- Patients unable to follow and respect the study procedures and judged inapt to respond to the questions required for the study due to linguistical, psychological, social, or geographical reasons.
- Patients not affiliated to the French social security system.
- Patients deprived of liberty, under guardianship, or unable to provide oral consent.
- Patients participating in a clinical study assessing a medicinal treatment (patients can participate in registries and observatories).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 30 locations
1
CHU Amiens-Picardie - Site Nord
Amiens, Somme, France, 80080
Actively Recruiting
2
CHU Besancon - Hopital Jean Minjoz
Besançon, France, 25000
Actively Recruiting
3
Polyclinique Reims Bezannes
Bezannes, France, 51430
Actively Recruiting
4
Chu Bordeaux Hopital Saint Andre
Bordeaux, France, 33075
Actively Recruiting
5
CHU Brest Hopital Morvan
Brest, France, 29609
Actively Recruiting
6
CHU de Caen
Caen, France, 14033
Actively Recruiting
7
Ch de Calais
Calais, France, 62107
Actively Recruiting
8
Ch William Morey
Chalon-sur-Saône, France, 71100
Actively Recruiting
9
CHU Clermont Ferrand - Hopital Gabriel Montpied
Clermont-Ferrand, France, 63000
Actively Recruiting
10
Chu Estaing
Clermont-Ferrand, France, 63003
Actively Recruiting
11
Hopital Henri Mondor
Créteil, France, 94010
Actively Recruiting
12
Chu Dijon
Dijon, France, 21000
Actively Recruiting
13
Hopital Franco Britannique
Levallois-Perret, France, 92300
Actively Recruiting
14
Hopital Claude Huriez
Lille, France, 59000
Actively Recruiting
15
CH de Martigues
Martigues, France, 13698
Actively Recruiting
16
CHU Montpellier
Montpellier, France, 34295
Actively Recruiting
17
Hopital Emile Muller
Mulhouse, France, 68070
Actively Recruiting
18
Hopital Hotel Dieu
Nantes, France, 44000
Actively Recruiting
19
Hopital Cochin
Paris, France, 75014
Actively Recruiting
20
Hopital Tenon
Paris, France, 75020
Actively Recruiting
21
Hopital Saint Louis (APHP) - Service Hematologic Senior
Paris, France, 75475
Actively Recruiting
22
CHU Lyon Sud
Pierre-Bénite, France, 69495
Actively Recruiting
23
Hopital Pontchaillou
Rennes, France, 35033
Actively Recruiting
24
Ch de Romans Sur Isere
Romans-sur-Isère, France, 26102
Actively Recruiting
25
Hopital Charles Nicolle
Rouen, France, 76031
Actively Recruiting
26
Chi Poissy Saint Germain En Laye
Saint-Germain-en-Laye, France, 78105
Actively Recruiting
27
Hopital Bégin
Saint-Mandé, France, 94160
Actively Recruiting
28
Hopital Larrey
Toulouse, France, 31000
Actively Recruiting
29
Ch de Valenciennes
Valenciennes, France, 59322
Actively Recruiting
30
CHU Nancy
Vandœuvre-lès-Nancy, France, 54511
Actively Recruiting
Research Team
P
Pfizer CT.gov Call Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here